Zy Therapeutics
- Biotech or pharma, therapeutic R&D
Zy Therapeutics is a drug development company that utilizes proven pharmacotherapeutics and novel delivery technologies to treat rare and unmet medical needs.
Zy Therapeutics is a preclinical stage Drug Development Company that specializes in Rare and Orphan neurological Diseases.
Our Company was born out of the idea that innovators can use new, innovative technologies to revolutionize the current drug development process and provide therapies to patients in need in a timely, cost-effective, and fair way.
Zy represents a revolutionary step forward in the creation of lean biopharmaceuticals that develop life-saving medications in shorter amounts of time and at a fraction of traditional costs.
Zy Therapeutics is developing Kamini® Oral Powder as a disease-modifying treatment for Sturge-Weber Syndrome, a rare, intractable epilepsy syndrome that currently has no treatments.